iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Neurofibromatosis (NF1 and NF2)

Neurofibromatosis (NF1 and NF2)

Overview and management of genetic disorders.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
NeurologyGeneticsDermatology

Clinical Guidelines

NF2-related schwannomatosis (NF2) – NHS England Highly Specialised Services
National

Recent iatroX Q&As

  • What are the key clinical features that differentiate Neurofibromatosis Type 1 (NF1) from Neurofibromatosis Type 2 (NF2)?Updated: 8/22/2025
  • How should I approach the genetic testing and counselling for a patient with a family history of Neurofibromatosis?Updated: 8/22/2025
  • What are the recommended surveillance protocols for patients with Neurofibromatosis to monitor for complications?Updated: 8/22/2025
  • When should I consider referring a patient with Neurofibromatosis for specialist assessment or management?Updated: 8/22/2025
  • What are the current guidelines for managing pain and other symptoms associated with neurofibromas in patients with NF1?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play